Conavi Medical Corp. CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.95% | -39.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.95% | -39.39% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.95% | -39.39% | |||
| SG&A Expenses | -15.91% | -9.02% | |||
| Depreciation & Amortization | 52.24% | -1.12% | |||
| Other Operating Expenses | -- | -109.71% | |||
| Total Operating Expenses | 37.34% | -10.77% | |||
| Operating Income | -38.42% | 9.55% | |||
| Income Before Tax | -30.99% | -79.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.99% | -79.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.99% | -79.88% | |||
| EBIT | -38.42% | 9.55% | |||
| EBITDA | -37.21% | 9.78% | |||
| EPS Basic | -26.65% | -37.94% | |||
| Normalized Basic EPS | -20.52% | -44.94% | |||
| EPS Diluted | -26.65% | -37.94% | |||
| Normalized Diluted EPS | -20.52% | -44.94% | |||
| Average Basic Shares Outstanding | 3.61% | 30.15% | |||
| Average Diluted Shares Outstanding | 3.61% | 30.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||